Common Name Ginkgo, Maidenhair Tree
Latin Binomial Ginkgo biloba L. Family: Onagraceae
Part(s) Used Leaf
Active Constituents

Terpene Trilactones
Ginkgolides A, B, C and J
Bilobalide

Flavonoids
Quercetin, Kaempferol and
Isorhamnetin (glycosides).

Therapeutic Effects Most clinical trials of Ginkgo have explored its effects in the treatment of cognitive deficiency or cerebral insufficiency. (61)(27) Ginkgo leaf extract is primarily used to treat symptoms arising from poor cerebral blood flow. Symptoms include: Poor memory, poor concentration, dizziness, tinnitus, anxiety, and disorientation. Ginkgo leaf extract is also used on patients who suffer from peripheral arterial occlusive disease. (62)(27)
Contra-indications In light of the pharmacological effects of Ginkgo, it is not suitable for self treatment. Ginkgo should not be used in patients with bleeding disorders. Read more

Read more

In light of the pharmacological effects of Ginkgo, it is not suitable for self treatment. Ginkgo should not be used in patients with bleeding disorders.

Drug Interactions
Ginkgo extract should be used with caution, and under the supervision of a doctor. Especially patients taking anticoagulants or anti-platelet agents. Inhibition of CYP2C9 has been documented.(63) Flavonoids are thought to inhibit CYP2CP, CYP1A2, CYP2E1, and CYP3A.

Pregnancy and lactation The use of Ginkgo leaf extracts should be avoided during pregnancy and lactation.

Close
Back to links
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
  • Text
Pharmacological Action

The combined activity of several Ginkgo phytoconstituents is generally considered to be responsible for its effects.

Cardiovascular effects
Ginkgo extract is believed to inhibit human platelet aggregation elicited by substances such as thrombin and collagen. (55)

Platelet-activating factor (PAF) antagonism
Ginkgolides have been reported to competitively inhibit the binding of PAF to its membrane receptor. (56)(57)(58)

Antioxidant
Ginkgo leaf extract scavenges several oxygen species, including hydroxyl, superoxide, and peroxyl radicals. (59)

Other effects
Ginkgo leaf extract and the flavonoid constituents bind to both oestrogen receptors (ER), alpha- and beta- receptors. At certain concentrations, Ginkgo extract and flavonoid constituents induced the proliferation of ER-positive MCF-7 human breast cancer cells. (60)

Food Use Seeds may be eaten. (17)
Herbal Use/Indication Concentrated extracts from Ginkgo leaves are used to improve cognitive deficiency, relieve symptoms of peripheral arterial occlusive disease, vertigo, and tinnitus of vascular origin.
Dosage

120-240mg of dry leaf extract orally every day in two or three divided doses to treat cognitive deficiency. (17)

120-160mg of dry leaf extract orally every day in two or three divided doses to treat peripheral arterial occlusive disease, vertigo, and tinnitus. (17)

Therapeutic Effects Although available data indicate that standardized extracts of Ginkgo leaf are well tolerated when used at recommended doses, (61)(65) there are several case reports in the literature of bleeding associated with the ingestion of Ginkgo biloba extracts. (1)

AHP

American Herbal Pharmacopoeia and Therapeutic Compendium. Analytical, quality control and therpeutic monographs. Santa Cruz, California: American Herbal Pharmacopeoia, 1997-2005.

Close
Back to links

BHP 1996

British Herbal Pharmcopoeia, 1996. Exeter: British Herbal Medicine Association, 1996.

Close
Back to links

BP 2007

British Pharmacopoeia 2007. London: The Stationery Office, 2007.

Close
Back to links

Complete German Commission E 1998

Blumenthal M et al., eds. The Complete German Commission E Monographs. Austin, Texas: American Botanical Council, 1998.

Close
Back to links

Martindale 35th Edition

Martindale. The Complete Drug Reference, 35th edn. (Sweetman S, ed.) London: Pharmaceutical Press, 2007.

Close
Back to links

Ph Eu 2007

European Phamcopoeia, 5th edn, and Supplements 5.1-5.7. Strasbourg: Council of Europe, 2004-2007.

Close
Back to links

US 29/NF24

United States Pharmacopeia 29 and National Formulary 24 and Supplements. Rockville, Maryland, US, United States Pharmacopeial Convention, 2006.

Close
Back to links

WHO Volume 1 1999

World Health Organization. WHO Monographs on Selected Medicinal Plants, vol.1. Geneva: World Health Organization, 1999.

Close
Back to links

Kleijen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992; 34: 352-358.

Close
Back to links

Schulz V, Hansel R, Tyler V. Rational Phytotherapy. A Physicians' Guide to Herbal Medicine. Berlin: Springer-Verlag, 1998.

Close
Back to links

Pittler MK, Ernst E. Ginko biloba extract for the treatment of intermittent claudication: a meta-analysis of randomised trials. Am J Med 2000; 108: 276-281.

Close
Back to links

Refeudis FV. Ginkgo biloba. From Chemistry to Clinic. Wiesbaden, Germany: Ullstein Medical, 1998.

Close
Back to links

Braquet P. The ginkoglides: potent platelet-activating factor antagonists isolated form Ginkgo biloba L. Chemistry, pharmacology and clinical applications. Drugs of the Future 1987; 12: 643-699.

Close
Back to links

Anonymous. Extract of Ginkgo biloba. FEBS 200; 478: 123-126.

Close
Back to links

Hosford D, et al. Natural antagonists of platelet-activating factor. Phytother Res 1988; 2: 1-17.

Close
Back to links

Maitra I et al. Peroxyl radical scavenging activity of Ginkgo biloboa extract EGb-761. Biochem Pharmacol 1995; 49: 1649-1655.

Close
Back to links

Oh SM, Chung KH. Estrogenic activities of Ginkgo biloba extracts. Life Sci 2004; 74: 1325-1335.

Close
Back to links

De Smet PAGM et al., eds. Adverse Effects of Herbal Drugs, vol. 3. Berlin: Springer-Verlag, 1993.

Close
Back to links

Barnes J, Anderson LA, Phillipson DJ. Herbal Medicines. Third edition. Grayslake, Il Phrmaceutical Press; 2007. 710p.

Close
Back to links